Expert Interview
A Second View: Understanding the Landscape of Type-2 Diabetes Treatments and the prevalence of Lilly's Mounjaro.
Ticker(s): LLY, NVO, AZNInstitution: Primary Care Associates
- Community Endocrinologist in rural area.
- Treats 750 patients with type 2 Diabetes.
- Prescribed Mounjaro to twelve patients.
On a scale of 1-10 how would you rate Mounjaro as an accessible option for treating type-2 Diabetes.
Added By: max_adminWhat proportion of patients do you prescribe Mounjaro for?
Added By: max_adminUnder what circumstances would you prescribe Mounjaro over another medication?
Added By: max_adminDo you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
